Please login to the form below

Not currently logged in

Topas Therapeutics appoints chief development officer and chief medical officer

Rupert Sandbrink joins from Forward Pharma

Topas Therapeutics has appointed Rupert Sandbrink as its new chief development officer and chief medical officer, a role that will see him lead the German group’s development and regulatory affairs.

Forging a 20-year-career spanning clinical development, regulatory and medical affairs and pharmacovigilance business, Dr Sandbrink’s expertise saw him most recently at Forward Pharma, where he served as executive vice president, multiple sclerosis/neurology and immunology.

Prior to that, he held several roles at Bayer, including vice president, head of experimental medicine of women’s health and common mechanism research.

Timm Jessen, chief executive officer, Topas, said: “Rupert has a long and successful track record of bringing drugs and biologics through clinical development and regulatory approval.

“He brings the critical expertise and experience that will help us immensely as we advance and prepare to enter our first program into the clinic. I am very excited to have him join the Topas team.”

At Topas, Dr. Sandbrink will guide projects into the clinic, design and execute clinical development programs and trials and lead the interactions with regulatory authorities.

3rd November 2017

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....